Ποια είναι η τιμή για Aspire Biopharma Holdings, Inc. (ASBP)

Η τιμή για Aspire Biopharma Holdings, Inc. (ASBP) είναι $7.25

Ποια είναι η κεφαλαιοποίηση αγοράς για Aspire Biopharma Holdings, Inc. (ASBP)

Η κεφαλαιοποίηση αγοράς για Aspire Biopharma Holdings, Inc. (ASBP) είναι $836.45K

Aspire Biopharma Holdings, Inc. (ASBP) Τιμή και Κεφαλαιοποίηση Αγοράς

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.

Η τιμή για ASBP	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$47,185,728 $836.45K	NVDA	$5.444T	+650,837,529.52%
$38,864,741 $836.45K	AAPL	$4.484T	+536,065,294.85%
$36,113,598 $836.45K	GOOG	$4.166T	+498,118,493.27%
$32,071,809 $836.45K	MSFT	$3.700T	+442,369,672.71%
$24,603,747 $836.45K	AMZN	$2.839T	+339,361,933.46%

Η τιμή για ASBP

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$47,185,728 $836.45K